https://www.selleckchem.com/products/ABT-263.html
The efficacy of technology-delivered cognitive-behavioral therapy (tCBT) for pediatric anxiety disorders (ADs) is uncertain as no meta-analysis has examined outcomes in trials that used structured diagnostic assessments at pre- and posttreatment. We carried out a systematic review and meta-analysis of randomized controlled trials (RCTs) of tCBT for pediatric ADs that included participants 18years of age with a confirmed primary AD according to a structured diagnostic interview. Nine studies with 711 participants were included. tCBT
Like
Comment
Share
